Diabetic Retinopathy and diabetics are two highly associated severe diseases in human. This study assesses the risk of getting Diabetic Retinopathy among the Diabetic patients in the Kalmunai region. In this hospital based cross sectional study, all the diabetic patients who were attending to the diabetic clinic of the Ashraff memorial hospital from January 2014 to December 2014 were screened for Diabetic Retinopathy and their demographic details were recorded. Obtained information was analyzed for estimating the risk for Diabetic Retinopathy among the diabetic patients and it was estimated as 13.16%. No difference in risk of getting Diabetic Retinopathy was observed among different age group, educated level and gender. Risk of getting Diabetic Retinopathy increases with the increase of the duration suffered by the diabetic. The relative risk of getting Diabetic Retinopathy for patients with diabetic for more 12 years is 3.55 times greater compared to the fresh diabetic patients.
In the series of quality monitoring schemes with exponentially weighted moving average, the exponentially weighted moving average distance square scheme was introduced for joint monitoring of process mean and variance. This scheme claims that it has a special feature that the control limits of the scheme are independent of sample size and therefore it gives more freedom to the users. However, this claim was not studied in detail. In this study, the control limits were found for this scheme through simulations, for different sample sizes with different combination of other scheme parameters. This study concludes that the control limits for designing this scheme are independent of sample size.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.